日本兴和医药

公司简介

兴和集团以兴和株式会社(Kowa Company,Ltd.)为核心，自1894年创业以来，有超过100年的历史并不断发展至今。 兴和株式会社医药事业部是日本最大的OTC药品和保健品生产企业之一，研发及生产超过100多种药物。集团下属医药事业部拥有3个生产工厂和2个研究所，业务范围涵盖处方药、非处方药、医疗器械、以及保健品的研发、生产和销售。市场涉及全球。 兴和（上海）医药咨询有限公司作为日本兴和株式会社全资附属的子公司于2007年在上海正式成立，涉及处方药和OTC药品/保健品等。 兴和制药（中国）有限公司于2013年7月9日正式注册成立，注册资本3000万美金，投资总额9000万美金，兴和制药（中国）肩负研发和生产，业务涉及处方药、OTC产品以及日用百货等。兴和制药（中国）的成立为中国业务的发展和成长提供了更多机遇，成为每个兴和员工施展才华的广阔平台。我们秉承充分整合、利用市场的优良资源，加强管理，全力呵护和改善服务品质；努力发挥聪明才智，同心同德，不辱使命，共同创造和分享美好明天！ Kowa Group is a complex corporate entity that consists of many associated companies centered on Kowa Company., Ltd. In our history of over 100 years since founded in 1894, we have continually made progress. Kowa (Shanghai) Pharma Consulting Co., Ltd. is established in Dec.2007, 100% wholly owned subsidiary of Kowa Company Ltd. In the charge of the marketing, advertising, marketing research, clinical development of drugs, health products, cosmetics, medical equipments that are agreed to authorize by Kowa Company in China. Kowa Pharmaceuticals (China) Co. Ltd was formally registered on July 9, 2013, registered capital of USD$30 million, total investment up to USD$90 million, aiming at research and development and production, business involves RX, OTC products and general merchandise, etc. The establishment of KPC provides more opportunities for the development and growth of business in China, also build a broader platform for every employee to display their talent.Integrating and utilizating of good resources, reinforcing of the management and improving the quality of the service are the philosophy of KPC. Let us work together to create a better tomorrow!